With stock valuations climbing steadily over the past two years and artificial intelligence (AI) budgets of the big tech firms climbing by the year, it's only prudent to wonder if a bubble is in the ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Meta Platforms (META) stock is 1.9% higher premarket after strong Q4 earnings and a lawsuit settlement with Donald Trump ...

Nasdaq, the second-largest global stock exchange by market cap, is setting its sights on a new frontier: quantum computing. This technology could revolutionize trading and risk management in financial ...

U.S. stock futures moved marginally higher on Thursday following the latest flurry of U.S. economic reports. Investors received the first reading on Q4 GDP. The data showed the U.S. economy expanded ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Tsai Capital, an investment management company, released its fourth quarter investor letter. A copy of the letter can be downloaded here. Tsai Capital celebrated 25 years track record in 2024. Tsai ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.